Home
About
Overview
Sharing Data
ORCID
Help
History (1)
An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancer.
An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancer. J Immunol. 2011 Jun 01; 186(11):6607-16.
View in:
PubMed
subject areas
Amino Acid Sequence
Amino Acid Sequence
Animals
Animals
Antibodies, Monoclonal
Antibodies, Monoclonal
Antibody Affinity
Antibody Affinity
Antibody Specificity
Antibody Specificity
Apoptosis
Apoptosis
Breast Neoplasms
Breast Neoplasms
Carcinoma, Ductal, Breast
Carcinoma, Ductal, Breast
Cell Line
Cell Line
Cell Line, Tumor
Cell Line, Tumor
Cell Survival
Cell Survival
Dose-Response Relationship, Drug
Dose-Response Relationship, Drug
Female
Female
HLA-A Antigens
HLA-A Antigens
HLA-A2 Antigen
HLA-A2 Antigen
Humans
Humans
Kinetics
Kinetics
Macrophage Migration-Inhibitory Factors
Macrophage Migration-Inhibitory Factors
Mice
Mice
Mice, Nude
Mice, Nude
Peptides
Peptides
Prognosis
Prognosis
Protein Binding
Protein Binding
Xenograft Model Antitumor Assays
Xenograft Model Antitumor Assays
authors with profiles
William C Dooley
William H Hildebrand